Use of recombinant activated Factor Seven in bleeding extracorporeal membrane oxygenation patients post cardiac surgery: a randomised prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN98382551

Enrollment

Registered

2005-09-30

Start date

2004-04-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal membrane oxygenation (ECMO) patients post cardiac surgery Circulatory System Extracorporeal membrane oxygenation patients (ECMO) post cardiac surgery

Interventions

1. Use of FVII 2. Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Post cardiac surgery patients

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Amount of post-operative bleeding 2. Use of human blood products	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026